Article
Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
Proceedings of the National Academy of Sciences of the United States of America - 28 Jul 2015
Yuan Chen-Ching, Muthu Priya, Kazmierczak Katarzyna, Liang Jingsheng, Huang Wenrui, Irving Thomas C, Kanashiro-Takeuchi Rosemeire M, Hare Joshua M, Szczesna-Cordary Danuta
Abstract excerpt
Myosin light chain kinase (MLCK)-dependent phosphorylation of the regulatory light chain (RLC) of cardiac myosin is known to play a beneficial role in heart disease, but the idea of a phosphorylation-mediated reversal of a hypertrophic cardiomyopathy (HCM) phenotype is novel. Our previous studies on transgenic (Tg) HCM-RLC mice revealed that the D166V (Aspartate166 → Valine) mutation-induced changes in heart...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
